• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

The bluest of blue: A new algae-based switch is lighting up biological research!

Bioengineer by Bioengineer
April 27, 2021
in Chemistry
Reading Time: 4 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers have identified a novel ion channel from a species of alga growing on land, that can be switched on by shorter wavelength of light

IMAGE

Credit: Image courtesy: Hideki Kandori from Nagoya Institute of Technology

Several organisms possess “ion channels” (gateways that selectively allow charged particles called ions to enter the cells and are integral for cell function) called “channelrhodopsins,” that can be switched on and off with the help of light. Different channelrhodopsins respond to different wavelengths in the light spectrum. These channels can be expressed in foreign organisms (animals even in human) by means of genetic engineering, which in turn finds applications in optogenetics, or the application of light to modulate cellular and gene functions. So far, the shortest wavelength that a channelrhodopsin responds to was blue.

However, recently, a group of scientists from the Nagoya Institute of Technology, Japan, and Jawaharlal Nehru University, India, have identified a channelrhodopsin that responds to an even shorter indigo blue wavelength of light. In their study published in Nature’s Communications Biology, the group of researchers, led by Professor Hideki Kandori and Associate Professor Satoshi P. Tsunoda, identified a novel channelrhodopsin, which they named KnChR, from a species of terrestrial alga called Klebsormidium nitens. “We chose this alga, because it is known to be responsive to light, but its photoreceptor domain has not been established,” reports Prof. Kandori. Unlike other discovered channelrhodopsins, KnChR was found to respond to indigo blue light (see Figure 1).

It is known that KnChR is made up of a seven-cell membrane spanning region, which forms the pore that allows the entry and exit of different ions. This region is followed by a protein moiety including a peptidoglycan binding domain. In order to investigate the properties of KnChR, the researchers performed extensive genetic and electrophysiological experiments.

What was perhaps the most exciting result was that they could identify the role of the “cytoplasmic domain.” All known channelrhodopsins have a large “cytoplasmic domain,” or region that is located in the internal area of the cell. As Prof. Kandori explains, “All currently known channelrhodopsins comprise a large cytoplasmic domain, whose function is elusive. We found that the cytoplasmic domain of KnChR modulates the ion channel properties.”

Accordingly, the results of the experiments showed that changing the lengths of the cytoplasmic domain caused the changes in ion channel closure. Particularly, the shortening of the domain resulted in increased channel ‘open time’ by more than ten-fold. In addition, the researchers also identified two arginine amino acid residues, namely R287 and R291, in the same region, which played an important role in the properties of generated light currents. They found that KnChR exhibited maximal sensitivity at 430 nm and 460 nm, making it the ‘bluest’ channelrhodopsin (see Figure 2).

Overall, the researchers have faith in the KnChR being helpful in biological systems requiring specific excitation parameters. When asked about the implications of these findings, Prof. Tsunoda, who is the corresponding author of the study suggests, “KnChR would expand the optogenetics tool kit, especially for dual light applications when short-wavelength excitation is required.” What this means is that the light-operated property of KnChR can be applied in targeted manipulation of an organism’s biological functions, in a research setting. A few examples would include manipulation of neuronal and myocyte activities.

Indeed, we can hope that the scope of this discovery would expand beyond the laboratory into real-world applications. These real-world applications could include cure for Alzheimer’s disease and heart diseases, light therapy for recovery from depression, and visual restoration.

###

About Professor Hideki Kandori from Nagoya Institute of Technology, Japan

Dr. Hideki Kandori is a Professor at the Department of Life Science and Applied Chemistry, specifically the Opto-Biotechnology Research Center at Nagoya Institute of Technology, Japan. Broadly, his fields of expertise include biophysics, structural biochemistry, functional biochemistry, bio-related chemistry, biological physics, chemical physics, soft matter physics, and basic chemistry. Some of the major projects he has worked in include the development of infrared spectroscopy through the rhodopsin study, mechanism of light-signal conversion in photoreceptive proteins, and mechanism of light-signal conversion in photoreceptive proteins. He has over 314 publications as research articles, review papers and books, with reputed publishers, to his credit.

About Associate Professor Satoshi P. Tsunoda from Nagoya Institute of Technology, Japan

Dr. Satoshi P. Tsunoda is an Associate Professor at Nagoya Institute of Technology, Japan. He studied biochemistry and biophysics at Tokyo Institute of Technology. He first grew interested in research on rhodopsins when he was a post-doc researcher at Humboldt University in Berlin (Prof. Peter Hegemann’s group). After returning to Japan, he was selected as a researcher for JST PRESTO program to carry out a study on enzyme-rhodopsins. He has a number of publications in the form of research articles, review papers and books, to his credit, and focuses on the research areas of biophysics, cell signaling, electrophysiology, protein biochemistry, and optogenetics.

Media Contact
Azusa Yabugami
[email protected]

Original Source

https://www.nitech.ac.jp/eng/news/2021/8942.html

Related Journal Article

http://dx.doi.org/10.1038/s42003-021-01755-5

Tags: BiologyBiomechanics/BiophysicsChemistry/Physics/Materials Sciences
Share12Tweet8Share2ShareShareShare2

Related Posts

McGill Study Identifies Montreal Snow Dumps and Inactive Landfills as Significant Methane Emitters

McGill Study Identifies Montreal Snow Dumps and Inactive Landfills as Significant Methane Emitters

October 17, 2025
Recursive Enzymatic Network Enables Multitask Molecular Processing

Recursive Enzymatic Network Enables Multitask Molecular Processing

October 17, 2025

How Focus Sharpens Sound Processing: The Brain’s Path to Better Listening

October 17, 2025

Eliminating Uncertainty in Shock Wave Predictions Through Advanced Computational Modeling

October 17, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1260 shares
    Share 503 Tweet 315
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    283 shares
    Share 113 Tweet 71
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    118 shares
    Share 47 Tweet 30
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    102 shares
    Share 41 Tweet 26

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Reevaluating Ineffective Practices in Pressure Injury Care

Improving Carbon Reduction Strategies with OCO and ICOS

Placental DNA Mutations, Stress, and Infant Emotions

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.